Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial

PurposeThe objective was to evaluate the influence of low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) [Lp(a)] on clinical outcomes in patients undergoing coronary artery bypass grafting (CABG).MethodsThis is a secondary analysis of a 5-year follow-up of the DACAB trial (NCT02201771),...

Full description

Bibliographic Details
Main Authors: Qixiang Yu, Qing Xue, Hao Liu, Junlong Hu, Rui Wang, Yuanyuan Song, Yanzai Zhou, Wei Zhang, Yunpeng Zhu, Qiang Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
coronary artery bypass grafting
lipoprotein(a) [Lp(a)]
low-density lipoprotein cholesterol (LDL-C)
lipids
major adverse cardiovascular events (MACE)
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1103681/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1103681/full

Similar Items